The market for cancer research is experiencing significant growth as the global burden of cancer continues to rise. The market is driven by the increasing need for innovative therapies, early detection methods, and personalized treatment approaches. Cancer research encompasses various areas such as genomics, immunotherapy, targeted therapies, and biomarker identification. The market is witnessing collaborations between academia, pharmaceutical companies, and research institutions to advance knowledge and develop novel interventions. However, challenges such as high research costs, regulatory complexities, and the need for large-scale clinical trials persist. The market for cancer research is expected to continue expanding as the focus on improving cancer outcomes and patient survival rates remains a top priority worldwide.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
